Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar;60(3):412-414.
doi: 10.1038/s41409-024-02495-w. Epub 2024 Dec 10.

Quantification of the FLT3 internal tandem duplication is a reliable marker for monitoring measurable residual disease in acute myeloid leukemia with FLT3-ITD mutations

Meng-Miao Wang #  1   2   3 , Si-Man Huang #  2   3 , Yuan-Hong Huang #  2   3 , Jian Zhang #  4 , Hui-Ying Li  2   3 , Shuai-Shuai Ge  2   3 , Chao-Ling Wan  2   3 , Miao Wang  2   3 , Hai-Hui Liu  2   3 , Han-Yu Cao  2   3 , Zi-Hao Wang  2   3 , Kai-Wen Tan  2   3 , Hong-Feng Pang  2   3 , Xiao-Yu Lyu  2   3 , Song-Bai Liu  5 , Hai-Ping Dai  6   7 , Sheng-Li Xue  8   9 , Qiao-Cheng Qiu  10   11
Affiliations

Quantification of the FLT3 internal tandem duplication is a reliable marker for monitoring measurable residual disease in acute myeloid leukemia with FLT3-ITD mutations

Meng-Miao Wang et al. Bone Marrow Transplant. 2025 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare no competing interests. Ethics approval and consent to participate: This study was approved by the Ethics Committee of the First Affiliated Hospital of Soochow University (2022-316). Patient data were collected after informed consent was obtained in accordance with the Declaration of Helsinki.

References

    1. Gale RE, Green C, Allen C, Mead AJ, Burnett AK, Hills RK, et al. Medical Research Council Adult Leukaemia Working Party. The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia. Blood. 2008;111:2776–84. - DOI - PubMed
    1. Döhner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140:1345–77. - DOI - PubMed
    1. Zhao JC, Agarwal S, Ahmad H, Amin K, Bewersdorf JP, Zeidan AM. A review of FLT3 inhibitors in acute myeloid leukemia. Blood Rev. 2022;52:100905. - DOI - PubMed
    1. Grob T, Sanders MA, Vonk CM, Kavelaars FG, Rijken M, Hanekamp DW, et al. Prognostic value of FLT3-Internal tandem duplication residual disease in acute myeloid leukemia. J Clin Oncol. 2023;41:756–65. - DOI - PubMed
    1. Liu SB, Qiu QC, Bao XB, Ma X, Li HZ, Liu YJ, et al. Pattern and prognostic value of FLT3-ITD mutations in Chinese de novo adult acute myeloid leukemia. Cancer Sci. 2018;109:3981–92. - DOI - PubMed - PMC

LinkOut - more resources